ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer
Open accessThe DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Abstract
Recently, nutraceutical bioactive compounds in foods have been discovered for their potential health benefits regarding the prevention of chronic disorders, such as cancer, and inflammatory, cardiovascular, and metabolic diseases. Dietary omega-3 polyunsaturated fatty acids (ω-3PUFAs), including alpha-linolenic acid, docosapentaenoic acid, and eicosapentaenoic acid, are mostly attractive. They are available for the customers worldwide from commonly used foods and/or as components of commercial food supplements. The anti-inflammatory and hypotriglyceridemic effects of these fatty acids are well known, whereas pro-inflammatory properties have been recognized in their dietary counterparts, the ω-6PUFAs. Both ω-3 and ω-6PUFAs contribute to the production of lipid mediators such as endocannabinoids that are notably involved in control of food intake, energy sensing, and food–related disorders. In this review, we present ω-3 and ω-6PUFAs and their derivatives, endocannabinoids; discuss the anti-obesity effects of ω-3PUFAs; their roles in inflammation and colorectal cancer development; and how their action can be co-preventative and co-therapeutic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence from preclinical and clinical studies indicates that omega-3 polyunsaturated fatty acids may enhance the metabolic benefits of GLP-1RAs and attenuate lean mass loss, primarily via anti-inflammatory pathways and modulation of protein synthesis”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [189]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“anti-inflammatory cytokines [2]; deregulated lipid and glucose metabolism in metabolic organs is thought to be a critical factor.”
BackgroundWeight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451 · cited 1×
“Among “metabolic sensors,” leptin is the major peripheral indicators of body metabolic reserves acting as satiety signal [48].”
BackgroundThe importance of the ratio of omega-6/omega-3 essential fatty acids
Simopoulos, A. P. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00253-6 · Cited by 4,131 · cited 1×
“Moreover, there are convincing proofs that a low ω-6/ω-3PUFA ratio is determinant for the inhibition of pathologies connected to the metabolic syndrome, as colorectal cancer [101].”
BackgroundSimopoulos, A. P. (2008) · Experimental Biology and Medicine · doi:10.3181/0711-mr-311 · Cited by 2,915 · cited 2×
“Due to agribusiness and modern agriculture western diets enclose unnecessary levels of omega-6 PUFAs but very low levels ofω-3PUFAs, leading to an unhealthyω-6/ω-3 proportion, instead of 1:1 that was during evolution [90].”
BackgroundOh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428
An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity
Simopoulos, A. (2016) · Nutrients · doi:10.3390/nu8030128 · Cited by 1,668 · cited 4×
“A high omega-6 fatty acid intake and a high ω-6/ω-3 ratio are connected with weight gain in both animal and human investigations, whereas a highω-3 FAs intake reductions the risk for weight gain [89].”
BackgroundInfluentialLeptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Omega-3 fatty acids and inflammatory processes: from molecules to man
Calder, P. C. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160474 · Cited by 1,456
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392 · cited 1×
“Consistently, CB1 activation increases food intake [44], whereas its pharmacological and genetic impairment reduces food assumption, protecting against the development of obesity, liver steatosis, and related inflammation [45,46].”
Background
Cited by
Omega-9 fatty acids: potential roles in inflammation and cancer management
Farag, M. A., & Gad, M. Z. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00329-0 · Cited by 169
“Omega-3 and omega-6 FAs are well characterized regarding their benefits to human health [2].”
BackgroundTraditional Fermented Foods and Beverages from around the World and Their Health Benefits
García, L. C., Rodríguez-Rugarcía, P., El-Kassis, E. G., Galicia, G., Meza-Jiménez, M. D. L., Baños-Lara, M. D. R., Zaragoza-Maldonado, D. S., & Pérez‐Armendáriz, B. (2022) · Microorganisms · doi:10.3390/microorganisms10061151 · Cited by 187
“, polyunsaturated fatty acids (PUFAs), may influence diverse aspects of immunity and metabolism [29].”
BackgroundResultSun, Y., Zhang, X., Hang, D., Lau, H. C.-H., Du, J., Liu, C., Xie, M., Pan, Y., Wang, L., Liang, C., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.07.005 · Cited by 186
Mititelu, M., Lupuliasa, D., Neacșu, S. M., Olteanu, G., Busnatu, Ș., Mihai, A., Popovici, V., Măru, N., Boroghină, S. C., Mihai, S., et al. (2024) · Foods · doi:10.3390/foods14010046 · Cited by 254
Patel, A., Desai, S. S., Mane, V. K., Enman, J., Rova, U., Christakopoulos, P., & Μάτσακας, Λ. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.01.006 · Cited by 179
Metadata
- Authors
- D’Angelo, S., Motti, M. L., & Meccariello, R.
- Affiliations
- Parthenope University of Naples (IT)
- Corresponding author
- Meccariello, Rosaria
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-09-10
- Volume
- 12
- Issue
- 9
- Pages
- 2751
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7551151
- OpenAlex
- W3083934892
- Cited by
- 250
- References
- 137
- Citations by year
- 2026: 31 · 2025: 51 · 2024: 64 · 2023: 38 · 2022: 40 · 2021: 25 · 2020: 1
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- CINECA IRIS Institutial research information system (Parthenope University of Naples) (submittedVersion)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca (Prin 2017 to RM, project code 20175MT5EM)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
- Keywords
- omega-3 polyunsaturated fatty acids, omega-6 fatty acids, obesity, colorectal cancer, endocannabinoids, anti-inflammatory activity, hypotriglyceridemic effect, alpha-linolenic acid, eicosapentaenoic acid, docosapentaenoic acid, nutraceuticals, dietary supplements, inflammation, cancer prevention
- MeSH terms
- Anti-Inflammatory Agents, Hypolipidemic Agents, Diet, Eating, Energy Metabolism, Humans, Inflammation, Obesity, Colorectal Neoplasms, Fatty Acids, Omega-3, Fatty Acids, Omega-6, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer. https://app.cochat.ai/papers/10.3390/nu12092751
- The paper
- D’Angelo, S., Motti, M. L., & Meccariello, R. (2020). ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer. Nutrients. https://doi.org/10.3390/nu12092751
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.